Conference Code: 20FR05ICCDDDD
Conference Aims and Objectives
The ICCDDDD 2020: 22nd International Conference on Clinical Drug Development and Drug Design
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Clinical Drug Development and Drug Design. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Clinical Drug Development and Drug Design.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Clinical Drug Development and Drug Design are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET
Federated conference series is an event that brings together significant number of recurring events; academic conferences, symposia, workshops, special sessions, and plenary talks in the field of science and technology since inception in 1999. Each event may run over any span of time within the conference days.
All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the International Science Index (ISI)
, Google Scholar
, Semantic Scholar
, and other index databases. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk. Impact Factor Indicators
Special Journal Issues
has teamed up with the Special Journal Issue on Clinical Drug Development and Drug Design
A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form
|Abstracts/Full-Text Paper Submission Deadline
||July 18, 2019
|Notification of Acceptance/Rejection
||November 18, 2019
|Final Paper (Camera Ready) Submission & Early Bird Registration Deadline
||January 18, 2020
||May 18 - 19, 2020
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for
Please refer to the Paper Submission GUIDE
before submitting your paper.
Selected Conference Papers
1) Patient Support Program in Pharmacovigilance: Foster Patient Confidence and ComplianceAtul Khurana, Rajul Rastogi, Hans-Joachim Gamperl 2) Corporate Governance and Corporate Social Responsibility: Research on the Interconnection of Both Concepts and Its Impact on Non-Profit OrganizationsHelene Eller 3) Representations of Childcare Robots as a Controversial IssueRaya A. Jones 4) Achieving Maximum Performance through the Practice of Entrepreneurial Ethics: Evidence from SMEs in NigeriaS. B. Tende, H. L. Abubakar 5) Understanding Narrative Transformations of Ebola in Negotiations of Epidemic RiskN. W. Paul, M. Banerjee 6) Net Regularity and Its Ethical Implications on Internet Stake HoldersNourhan Elshenawi 7) The Interaction between Human and Environment on the Perspective of Environmental EthicsMella Ismelina Farma Rahayu 8) Creation of a Care Robot Impact AssessmentE. Fosch-Villaronga 9) Auditor with the Javanese Characters and Non Javanese in Audit Firm: Conflict of InterestKrisna Damayanti, Lilis Ardini 10) Ethical Perspectives on Implementation of Computer Aided Design Curriculum in Architecture in Nigeria: A Case Study of Chukwuemeka Odumegwu Ojukwu University, UliKelechi E. Ezeji 11) Social Media and Counseling: Opportunities, Risks and Ethical ConsiderationsKyriaki G. Giota, George Kleftaras 12) Transparency of Audit Firms in CroatiaMarko Čular 13) A Study of Management Principles Incorporating Corporate Governance and Advocating Ethics to Reduce Fraud at a South African BankRoshan Jelal, Charles Mbohwa 14) Behavior of Engineering Students in Kuwait UniversityM. A. Al-Ajmi, R. S. Al-Kandari 15) The Effect of Transformer’s Vector Group on Retained Voltage Magnitude and Sag Frequency at Industrial Sites Due to FaultsM. N. Moschakis, V. V. Dafopoulos, I. G. Andritsos, E. S. Karapidakis, J. M. Prousalidis
Similar conferences about Pharmacological and Pharmaceutical Sciences